Endymed Medical Ltd. acquired Applisonix, Ltd. (TASE: APLS) in a reverse merger transaction on January 2, 2012. As part of consideration, Endymed Medical received one share and warrant of Applisonix representing 53.6% of its stake. Moshe Ne'eman of Shiboleth, Yisraeli, Roberts, Zisman & Co acted as legal advisor for Applisonix. Endymed Medical Ltd. completed the acquisition of Applisonix, Ltd. (TASE: APLS) in a reverse merger transaction on January 2, 2012.